The 20 Best Pancreatic Ductal Adenocarcinoma Doctors in The United States

Charles Yeo is an Oncologist and a General Surgeon practicing medicine in Philadelphia, Pennsylvania. Dr. Yeo is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Yeo is board certified in Surgery. Dr. Yeo is currently accepting new patients.

Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Burkhart is board certified in American Board Of Surgery.

I enjoy traveling, dancing and food. Dr. Shroff is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Shroff is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Shroff is currently accepting new patients.

Dr. Michael G. Goggins is a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine. He serves as director of the Pancreatic Cancer Early Detection Laboratory and is an attending physician in medicine in the Division of Gastroenterology and Hepatology at The Johns Hopkins Hospital. He is the Sol Goldman Professor of Pancreatic Cancer Research. Dr. Goggins’ research interests include developing tests to improve the early detection in pancreas cancer, evaluating outcomes of pancreatic surveillance and identifying gene variants responsible for inherited susceptibility to pancreatic cancer. He obtained his medical degree in 1988 from Trinity College of the University of Dublin, Ireland. He completed a residency in internal medicine and a fellowship in Gastroenterology at St. James' Hospital in Dublin. He obtained his Membership of the Royal College of Physicians of Ireland in 1991 and his European Diploma in Gastroenterology in 1995. He joined the Johns Hopkins faculty in 1999. Dr. Goggins is a member of the Royal College of Physicians of Ireland. He sits on the editorial boards of Gut. Dr. Goggins is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatectomy, and Endoscopy.

Gulam Manji, M.D., Ph.D. is an Associate Professor of Medicine at Columbia University Medical Center. Dr. Manji received his M.D. degree from Ross University School of Medicine in 2009 and completed his residency in internal medicine at Albany Medical College. He then completed his fellowship in Hematology/Oncology at NewYork-Presbyterian/Columbia, where his clinical focus was on the treatment of gastrointestinal malignancies, melanoma, and sarcoma under the mentorship of Dr. Gary Schwartz, Chief of Hematology and Oncology.Dr. Manji conducts translational research with the overall goal to developing new treatments for cancer. His focus is in gastrointestinal malignancies, particularly pancreas adenocarcinoma, on which he is conducting preclinical combination immunotherapy studies on genetically engineered mice with pancreas cancer in the Olive laboratory at the Herbert Irving Comprehensive Cancer Center. The combination immunotherapy preclinical proposal received the Young Investigator Award from the American Society of Clinical Oncology-2015. The goal of these preclinical studies is to bring promising new therapies to the clinic in an early phase clinical trials Dr. Manji's research career in identifying new genes and their implication in disease has led to numerous key publications and an issued patent.Dr. Manji cares for patients with gastrointestinal malignancies, with a particular focus on pancreatic and liver cancers, and sarcomas. He is the principal investigator of an investigator-initiated multicenter clinical trial that he wrote with Dr. Gary Schwartz in sarcoma and malignant peripheral nerve sheath tumors and is responsible for clinical trials conducted in liver, bile duct, gallbladder, and pancreas cancers at Columbia University Medical Center. Dr. Manji is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Peripheral Nerve Sheath Tumor, Splenectomy, and Pancreatectomy. Dr. Manji is board certified in Internal Medicine and Medical Oncology. Dr. Manji is currently accepting new patients.

Andrew Hendifar is a Hematologist practicing medicine in Los Angeles, California. Dr. Hendifar is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy.

Christopher Wolfgang is a General Surgeon practicing medicine in New York, New York. Dr. Wolfgang is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Stephen Pandol is a Gastroenterologist practicing medicine in West Hollywood, California. Dr. Pandol is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Chronic Pancreatitis, Acute Pancreatitis, Endoscopy, and Gallbladder Removal.

Kenneth Yu is an Oncologist practicing medicine in New York, New York. Dr. Yu is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization. Dr. Yu is currently accepting new patients.

Nathan Bahary is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Bahary is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus. In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies. Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001. Dr. Ko is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Stomach Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Ko is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ko is currently accepting new patients.

Elizabeth Jaffee is an Internal Medicine provider practicing medicine in Baltimore, Maryland. Dr. Jaffee is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Fibrolamellar Carcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Susan Tsai is a General Surgeon practicing medicine in Milwaukee, Wisconsin. Dr. Tsai is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Ampullary Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Andrea Bullock is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Bullock is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, Gallbladder Adenocarcinoma, Muscle Invasive Bladder Cancer, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery. Dr. Bullock is board certified in American Board Of Internal Medicine.

Eugene Koay is a Radiation Oncologist practicing medicine in Houston, Texas. He has been practicing medicine for over 17 years. Dr. Koay is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Ching-wei Tzeng is a General Surgeon practicing medicine in Houston, Texas. Dr. Tzeng is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Hepatectomy, and Pancreatectomy.

Douglas B. Evans, MD is the Donald C. Ausman Family Foundation Professor of Surgery and Chair of the Department of Surgery at the Medical College of Wisconsin. Prior to joining the Medical College of Wisconsin in 2009, he was the Hamill Foundation Distinguished Professor of Surgery at The University of Texas MD Anderson Cancer Center. Dr. Evans completed a general surgery residency at Dartmouth followed by a surgical oncology fellowship at The University of Texas MD Anderson Cancer Center. He received his medical degree from Boston University School of Medicine and his Bachelor of Science from Bates College in Lewiston, Maine. He is board-certified in surgery, and his clinical interests include treatment of pancreatic cancer and tumors of the endocrine system (thyroid, parathyroid, adrenal and gastrointestinal neuroendocrine tumors). Dr. Evans holds appointments at Froedtert Hospital, the Clement J. Zablocki VA Medical Center, Children’s Wisconsin and St. Francis Hospital.Dr. Evans has devoted his professional career to the research and treatment of pancreatic cancer and inherited endocrine syndromes. His interests include translational laboratory research in the biology of pancreatic cancer and in clinical trial development. He has completed a number of investigator-initiated clinical trials, emphasized the importance of treatment sequencing to include a variety of strategies for neoadjuvant therapy and described a number of novel techniques for vascular resection and reconstruction at the time of pancreatectomy. Research support has included a National Cancer Institute Specialized Programs of Research Excellence (NIH P20 SPORE) pancreatic cancer grant. At MD Anderson, his endocrine surgery group worked extensively on the genotype-phenotype correlations in multiple endocrine neoplasia syndromes and they were the first to define the role for ultrasound in the preoperative management of patients with thyroid cancer. Dr. Evans has authored or co-authored over 400 journal articles, over 90 book chapters and has edited eight books. He has delivered countless invited and named lectureships nationally and internationally including the American College of Surgeons Traveling Fellowship to Australia and New Zealand in 1999. He served as President of the American Association of Endocrine Surgeons in 2010-2011.Since joining MCW, Dr. Evans has grown the faculty across all clinical divisions in the department, emphasized the importance of innovation and discovery and championed the principles of inclusion and diversity. The MCW surgical residency program has led the way in supporting the careers of young women in general and subspecialty surgery. The MCW Program in Pancreatic Cancer was recently endowed by the LaBahn family and is one of very few endowed Pancreatic Cancer Research Programs in this country. Dr. Evans is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreatectomy, and Thyroidectomy. Dr. Evans is board certified in Surgery. Dr. Evans is currently accepting new patients.

Mark Truty is a General Surgeon practicing medicine in Rochester, Minnesota. Dr. Truty is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Eric Collisson is an Oncologist practicing medicine in San Francisco, California. Dr. Collisson is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Tissue Biopsy, and Pancreatectomy.

Nipun Merchant is a Surgical Oncologist practicing medicine in Miami, Florida. Dr. Merchant is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Merchant is currently accepting new patients.